New! Interventional Cardiology Podcast Series: Anticoagulants vs. Filter Devices for Left Atrial Appendage Closure
Which option is best for managing stroke prevention in patients at risk for bleeding?
Jonathan P. Piccini, MD, MHS and Sean D. Pokorney, MD, MBA discuss the case of a 68-year-old man with a history of diabetes, hypertension, peripheral artery disease, and gastrointestinal bleeds. They refer to the PROTECT AF Trial and the PREVAIL Trial to assess left atrial appendage closure with the FDA-approved Watchman filter device as an alternative to warfarin therapy.